Lobbying Relationship

Client

Magnet Strategy Group

More records

Lobbying firm

The Ross Group, LLC

More records

  • Importance of biopharmaceutical platforms to strengthen preparedness against future outbreaks in emerging infectious disease.

Duration: to

General Issues: Health Issues

Spending: about $51,000 (But it's complicated. Here's why.)

Agencies lobbied since 2016: U.S. Senate, House of Representatives

Affiliated organizations: Medicago Inc.

Related Foreign Entities: Mitsubishi Tanabe Pharma (Osaka, JPN); contribution to lobbying: $0; ownership 60%

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Shalla Ross Prof Staff Member, Labor HHS Cmtee, Subcmtee on Aging; Legis Aide, Senator Judd Gregg; Sr Leg Asst/Leg Dir.Rep. Phil Crane; Staff Dir Rules Cmtee Subcmtee Budget & Leg Process; Sr Policy Advisor/Policy Dir, House Republican Conference

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page